Global Porphyrias Drugs Market Insights, Research Forecast to 2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 114

Report ID: 5343

Porphyria is a group of diseases in which substances called porphyrins build up, negatively affecting the skin or nervous system.
The global Porphyrias Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Porphyrias Drugs market based on company, product type, end user and key regions.

This report studies the global market size of Porphyrias Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Porphyrias Drugs in these regions.
This research report categorizes the global Porphyrias Drugs market by top players/brands, region, type and end user. This report also studies the global Porphyrias Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Lundbeck
Recordati Rare Diseases
Teva Pharmaceutical
Apotex

Market size by Product
Oral
Injectable
Market size by End User
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Porphyrias Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Porphyrias Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Porphyrias Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Porphyrias Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Porphyrias Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Porphyrias Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Study Coverage
1.1 Porphyrias Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Porphyrias Drugs Market Size Growth Rate by Product
1.4.2 Oral
1.4.3 Injectable
1.5 Market by End User
1.5.1 Global Porphyrias Drugs Market Size Growth Rate by End User
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Porphyrias Drugs Market Size
2.1.1 Global Porphyrias Drugs Revenue 2014-2025
2.1.2 Global Porphyrias Drugs Sales 2014-2025
2.2 Porphyrias Drugs Growth Rate by Regions
2.2.1 Global Porphyrias Drugs Sales by Regions
2.2.2 Global Porphyrias Drugs Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Porphyrias Drugs Sales by Manufacturers
3.1.1 Porphyrias Drugs Sales by Manufacturers
3.1.2 Porphyrias Drugs Sales Market Share by Manufacturers
3.1.3 Global Porphyrias Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Porphyrias Drugs Revenue by Manufacturers
3.2.1 Porphyrias Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Porphyrias Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Porphyrias Drugs Price by Manufacturers
3.4 Porphyrias Drugs Manufacturing Base Distribution, Product Types
3.4.1 Porphyrias Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Porphyrias Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Porphyrias Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Porphyrias Drugs Sales by Product
4.2 Global Porphyrias Drugs Revenue by Product
4.3 Porphyrias Drugs Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Porphyrias Drugs Breakdown Data by End User

6 North America
6.1 North America Porphyrias Drugs by Countries
6.1.1 North America Porphyrias Drugs Sales by Countries
6.1.2 North America Porphyrias Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Porphyrias Drugs by Product
6.3 North America Porphyrias Drugs by End User

7 Europe
7.1 Europe Porphyrias Drugs by Countries
7.1.1 Europe Porphyrias Drugs Sales by Countries
7.1.2 Europe Porphyrias Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Porphyrias Drugs by Product
7.3 Europe Porphyrias Drugs by End User

8 Asia Pacific
8.1 Asia Pacific Porphyrias Drugs by Countries
8.1.1 Asia Pacific Porphyrias Drugs Sales by Countries
8.1.2 Asia Pacific Porphyrias Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Porphyrias Drugs by Product
8.3 Asia Pacific Porphyrias Drugs by End User

9 Central & South America
9.1 Central & South America Porphyrias Drugs by Countries
9.1.1 Central & South America Porphyrias Drugs Sales by Countries
9.1.2 Central & South America Porphyrias Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Porphyrias Drugs by Product
9.3 Central & South America Porphyrias Drugs by End User

10 Middle East and Africa
10.1 Middle East and Africa Porphyrias Drugs by Countries
10.1.1 Middle East and Africa Porphyrias Drugs Sales by Countries
10.1.2 Middle East and Africa Porphyrias Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Porphyrias Drugs by Product
10.3 Middle East and Africa Porphyrias Drugs by End User

11 Company Profiles
11.1 Lundbeck
11.1.1 Lundbeck Company Details
11.1.2 Company Business Overview
11.1.3 Lundbeck Porphyrias Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Lundbeck Porphyrias Drugs Products Offered
11.1.5 Lundbeck Recent Development
11.2 Recordati Rare Diseases
11.2.1 Recordati Rare Diseases Company Details
11.2.2 Company Business Overview
11.2.3 Recordati Rare Diseases Porphyrias Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Recordati Rare Diseases Porphyrias Drugs Products Offered
11.2.5 Recordati Rare Diseases Recent Development
11.3 Teva Pharmaceutical
11.3.1 Teva Pharmaceutical Company Details
11.3.2 Company Business Overview
11.3.3 Teva Pharmaceutical Porphyrias Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Teva Pharmaceutical Porphyrias Drugs Products Offered
11.3.5 Teva Pharmaceutical Recent Development
11.4 Apotex
11.4.1 Apotex Company Details
11.4.2 Company Business Overview
11.4.3 Apotex Porphyrias Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Apotex Porphyrias Drugs Products Offered
11.4.5 Apotex Recent Development

12 Future Forecast
12.1 Porphyrias Drugs Market Forecast by Regions
12.1.1 Global Porphyrias Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Porphyrias Drugs Revenue Forecast by Regions 2019-2025
12.2 Porphyrias Drugs Market Forecast by Product
12.2.1 Global Porphyrias Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Porphyrias Drugs Revenue Forecast by Product 2019-2025
12.3 Porphyrias Drugs Market Forecast by End User
12.4 North America Porphyrias Drugs Forecast
12.5 Europe Porphyrias Drugs Forecast
12.6 Asia Pacific Porphyrias Drugs Forecast
12.7 Central & South America Porphyrias Drugs Forecast
12.8 Middle East and Africa Porphyrias Drugs Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Porphyrias Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer